Predicate |
Object |
contentType |
Journal Article |
endingPage |
138 |
issn |
0306-5251 1365-2125 |
issueIdentifier |
1 |
pageRange |
137-138 |
publicationName |
British Journal of Clinical Pharmacology |
startingPage |
137 |
bibliographicCitation |
Dolton MJ, McLachlan AJ. Clinical importance of the CYP2C19*17 variant allele for voriconazole. Brit J Clinical Pharma. 2010 Dec 09;71(1):137–8. doi: 10.1111/j.1365-2125.2010.03801.x. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2944f826fcd6b503eef31cec32d184af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60820f64fb769179fe5be31643d313a1 |
date |
2010-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3018036 https://doi.org/10.1111/j.1365-2125.2010.03801.x https://pubmed.ncbi.nlm.nih.gov/21143511 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1743 https://portal.issn.org/resource/ISSN/1365-2125 https://portal.issn.org/resource/ISSN/0306-5251 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Clinical importance of the CYP2C19*17 variant allele for voriconazole |
discusses |
http://id.nlm.nih.gov/mesh/M0021911 http://id.nlm.nih.gov/mesh/M0001399 http://id.nlm.nih.gov/mesh/M0001774 http://id.nlm.nih.gov/mesh/M0006857 http://id.nlm.nih.gov/mesh/M0268951 http://id.nlm.nih.gov/mesh/M0132976 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0590604 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D011743Q000378 http://id.nlm.nih.gov/mesh/D000935Q000627 http://id.nlm.nih.gov/mesh/D001189Q000235 http://id.nlm.nih.gov/mesh/D014230Q000378 http://id.nlm.nih.gov/mesh/D004364Q000378 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D000483 http://id.nlm.nih.gov/mesh/D065819 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D065731 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b360533648df9c14281910a5ec4e45f0 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71616 |